Customized services to meet your needs.
35+ languages
Our team of specialists is proficiently trained in AE and PQC reporting while also providing exceptional levels of service.
Experience with Community Management Services across the globe. Complying with various regulatory bodies.
Facebook, Instagram, LinkedIn, X, and more.
ProPharma diligently oversees our clients' social media channels, monitoring for any emerging Adverse Events or Product Complaints. Whenever we spot something reportable, we promptly document and report our findings within the required timeframe, ensuring that critical information is not missed.
ProPharma actively engages with consumer comments and inquiries across various social media platforms acting as the client. We utilize a client-approved standard response document tailored specifically for these interactions. Whether responding publicly to comments beneath posts or privately through direct messages, ProPharma ensures that each interaction is professional, appropriate, and non-promotional. With this service, ProPharma will also remove inappropriate comments from your posts to keep your company’s image professional.
We are dedicated to enhancing the health and well-being of consumers through our comprehensive Community Management services. Whether you need reliable Social Media Monitoring Services or full service including Social Response Management, our team of experts is here to help.
July 27, 2026
Discover how ProPharma streamlines clinical trial study start-up, ensuring predictable activation and reducing risks from feasibility to first patient in.cl
July 23, 2026
The FDA's transition to the QMSR simplifies compliance, emphasizing risk management and aligning with global standards for medical devices compared to QMR.
July 20, 2026
Discover effective strategies for building relationships with clinical trial sites to streamline the study start-up process and enhance activation timelines.
July 8, 2026
ProPharma unveils an AI-assisted capability to enhance ANDA submission development, improving efficiency and maintaining regulatory excellence for clients.
June 18, 2026
ProPharma welcomes Kevin van Dooren as Vice President, HEOR and Market Access, strengthening integrated EU regulatory, HTA, reimbursement, and market access capabilities for life sciences companies.
May 27, 2026
ProPharma announces Adrian Pencak as Chief Commercial Officer, bringing 25 years of leadership experience to enhance global commercial capabilities and client partnerships.
.png?width=320&height=185&name=2%20-%20Clinical%20Research%20Solutions%20%20(650%20x%20425%20px).png)
.png?width=320&height=185&name=6%20-%20Medical%20Information%20%20(650%20x%20425%20px).png)
.png?width=320&height=185&name=4%20-%20Quality%20%26%20Compliance%20(650%20x%20425%20px).png)